"Obesity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Descriptor ID |
D009765
|
| MeSH Number(s) |
C18.654.726.500 C23.888.144.699.500 E01.370.600.115.100.160.120.699.500 G07.100.100.160.120.699.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Obesity".
Below are MeSH descriptors whose meaning is more specific than "Obesity".
This graph shows the total number of publications written about "Obesity" by people in this website by year, and whether "Obesity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 2 | 0 | 2 |
| 2004 | 3 | 0 | 3 |
| 2005 | 7 | 1 | 8 |
| 2006 | 0 | 3 | 3 |
| 2007 | 3 | 9 | 12 |
| 2008 | 4 | 1 | 5 |
| 2009 | 8 | 3 | 11 |
| 2010 | 5 | 5 | 10 |
| 2011 | 3 | 1 | 4 |
| 2012 | 9 | 2 | 11 |
| 2013 | 12 | 2 | 14 |
| 2014 | 11 | 3 | 14 |
| 2015 | 9 | 2 | 11 |
| 2016 | 32 | 13 | 45 |
| 2017 | 317 | 145 | 462 |
| 2018 | 301 | 160 | 461 |
| 2019 | 95 | 57 | 152 |
| 2020 | 107 | 73 | 180 |
| 2021 | 50 | 61 | 111 |
| 2022 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Obesity" by people in Profiles.
-
Body Mass Index and Mortality in Coronavirus Disease 2019 and Other Diseases: A Cohort Study in 35,506 ICU Patients. Crit Care Med. 2022 01 01; 50(1):e1-e10.
-
Worldwide association of lifestyle-related factors and COVID-19 mortality. Ann Med. 2021 12; 53(1):1528-1533.
-
Resveratrol supplementation reduces ACE2 expression in human adipose tissue. Adipocyte. 2021 12; 10(1):408-411.
-
Thrombogenicity markers for early diagnosis and prognosis in COVID-19: a change from the current paradigm? Blood Coagul Fibrinolysis. 2021 Dec 01; 32(8):544-549.
-
Physical activity may mitigate COVID-19 infections in people with obesity: A call to action. Obesity (Silver Spring). 2021 12; 29(12):1987-1989.
-
Coronavirus Disease 2019 Severity in Obese Patients May Be Linked to Viral Load and Immune Response. J Infect Dis. 2021 11 16; 224(9):1449-1451.
-
Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System Beneficiaries. J Infect Dis. 2021 11 16; 224(9):1462-1472.
-
Temporal changes in soluble angiotensin-converting enzyme 2 associated with metabolic health, body composition, and proteome dynamics during a weight loss diet intervention: a randomized trial with implications for the COVID-19 pandemic. Am J Clin Nutr. 2021 11 08; 114(5):1655-1665.
-
Malnutrition in patients with COVID-19: assessment and consequences. Curr Opin Clin Nutr Metab Care. 2021 11 01; 24(6):543-554.
-
Lung Function Levels Influence the Association between Obesity and Risk of COVID-19. Am J Respir Crit Care Med. 2021 11 01; 204(9):1106-1108.